Atlas Trials

Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi

Clinical trial NCT02911415 · COMPLETED

Trial details

NCT number
NCT02911415
Sponsor
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Status
COMPLETED
Study type
OBSERVATIONAL
Ebola Hemorrhagic Fever
Start date
2016-10-01
Primary completion
2017-12-25
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.